PRKN and Parkinson disease: Small-molecule activators of PINK1 and parkin, or inhibitors of mTOR, USP30, and pSer65Ub phosphatases, are promising therapeutic targets for enhancing mitophagy in PD, and several of them have been found efficacious44.